221,046 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Acquired by BNP Paribas Financial Markets

BNP Paribas Financial Markets acquired a new stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 221,046 shares of the company's stock, valued at approximately $4,321,000. BNP Paribas Financial Markets owned about 0.18% of Privia Health Group as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Algert Global LLC lifted its stake in shares of Privia Health Group by 639.1% in the 4th quarter. Algert Global LLC now owns 108,048 shares of the company's stock worth $2,112,000 after acquiring an additional 93,429 shares during the period. Alyeska Investment Group L.P. lifted its position in Privia Health Group by 20.0% in the fourth quarter. Alyeska Investment Group L.P. now owns 300,000 shares of the company's stock worth $5,865,000 after purchasing an additional 50,000 shares during the period. Northern Trust Corp increased its position in shares of Privia Health Group by 14.2% during the 4th quarter. Northern Trust Corp now owns 1,392,641 shares of the company's stock valued at $27,226,000 after purchasing an additional 173,563 shares during the period. Tudor Investment Corp ET AL raised its stake in shares of Privia Health Group by 16.5% in the 4th quarter. Tudor Investment Corp ET AL now owns 267,899 shares of the company's stock worth $5,237,000 after buying an additional 37,904 shares in the last quarter. Finally, Two Sigma Securities LLC acquired a new stake in shares of Privia Health Group in the fourth quarter valued at $463,000. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Stock Performance

Shares of PRVA stock traded down $0.28 during trading hours on Tuesday, hitting $24.72. The company had a trading volume of 54,477 shares, compared to its average volume of 753,563. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $26.09. The firm's fifty day moving average is $23.38 and its 200 day moving average is $22.61. The firm has a market capitalization of $3.01 billion, a price-to-earnings ratio of 246.99, a PEG ratio of 3.47 and a beta of 0.87.

Analysts Set New Price Targets

PRVA has been the topic of several research reports. Canaccord Genuity Group boosted their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research report on Friday, February 28th. Truist Financial lifted their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research report on Thursday, April 10th. Needham & Company LLC restated a "buy" rating and issued a $30.00 target price on shares of Privia Health Group in a report on Thursday, April 10th. Barclays raised their price objective on Privia Health Group from $21.00 to $23.00 and gave the stock an "equal weight" rating in a research report on Thursday, April 10th. Finally, JMP Securities reissued a "market outperform" rating and set a $29.00 target price on shares of Privia Health Group in a research note on Monday, April 28th. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $27.38.

Insider Transactions at Privia Health Group

In other news, Director Matthew Shawn Morris sold 10,309 shares of the business's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total transaction of $240,508.97. Following the completion of the transaction, the director now directly owns 59,792 shares in the company, valued at approximately $1,394,947.36. The trade was a 14.71% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO David Mountcastle sold 5,630 shares of the stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the sale, the chief financial officer now owns 179,676 shares in the company, valued at approximately $4,021,148.88. This trade represents a 3.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 51,579 shares of company stock valued at $1,226,367 in the last three months. 10.70% of the stock is owned by corporate insiders.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.